LegoChem Biosciences Revenue vs. Net Income

141080 Stock  KRW 111,200  12,200  12.32%   
Based on LegoChem Biosciences' profitability indicators, LegoChem Biosciences may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess LegoChem Biosciences' ability to earn profits and add value for shareholders.
For LegoChem Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LegoChem Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LegoChem Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LegoChem Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LegoChem Biosciences over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between LegoChem Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if LegoChem Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LegoChem Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

LegoChem Biosciences Net Income vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining LegoChem Biosciences's current stock value. Our valuation model uses many indicators to compare LegoChem Biosciences value to that of its competitors to determine the firm's financial worth.
LegoChem Biosciences is the top company in revenue category among its peers. It also is number one stock in net income category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value LegoChem Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LegoChem Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

LegoChem Revenue vs. Competition

LegoChem Biosciences is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 694.65 Billion. LegoChem Biosciences holds roughly 32.16 Billion in revenue claiming about 5% of equities under Health Care industry.

LegoChem Net Income vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

LegoChem Biosciences

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
32.16 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

LegoChem Biosciences

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(23.39 B)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

LegoChem Net Income Comparison

LegoChem Biosciences is currently under evaluation in net income category among its peers.

LegoChem Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in LegoChem Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LegoChem Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of LegoChem Biosciences' change in net profit over the period of time. It can combine multiple indicators of LegoChem Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and ADC platform. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea. LegoChem Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.

LegoChem Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on LegoChem Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LegoChem Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LegoChem Biosciences' important profitability drivers and their relationship over time.

Use LegoChem Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LegoChem Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LegoChem Biosciences will appreciate offsetting losses from the drop in the long position's value.

LegoChem Biosciences Pair Trading

LegoChem Biosciences Pair Trading Analysis

The ability to find closely correlated positions to LegoChem Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LegoChem Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LegoChem Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LegoChem Biosciences to buy it.
The correlation of LegoChem Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LegoChem Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LegoChem Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LegoChem Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your LegoChem Biosciences position

In addition to having LegoChem Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Beers Thematic Idea Now

Beers
Beers Theme
Companies involved in production and distribution of domestic and international beer. The Beers theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in LegoChem Stock

To fully project LegoChem Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of LegoChem Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include LegoChem Biosciences' income statement, its balance sheet, and the statement of cash flows.
Potential LegoChem Biosciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although LegoChem Biosciences investors may work on each financial statement separately, they are all related. The changes in LegoChem Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on LegoChem Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.